Sister-chromatid exchange frequencies in fibroblasts and lymphocytes of patients with systemic lupus erythematosus.
Sister-chromatid exchange (SCE) frequencies have been measured in lymphocytes and fibroblasts of patients with systemic lupus erythematous (SLE) and healthy controls, and in lymphocytes of control patients with serum anti-nuclear antibodies (ANA) but no other disease manifestations of SLE. The SCEs of SLE lymphocytes were higher than those of the controls but the SCEs of the SLE fibroblasts did not differ from those of the controls. The SCEs of the controls with positive ANA did not differ significantly from those of the healthy controls. There was no correlation between SCE frequencies of the SLE lymphocytes and disease activity determined by many clinical and laboratory measurements. Primary and secondary DNA-repair defects in SLE cells are considered.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D000974:Antibodies, Antinuclear / Q000032:analysis; D002478:Cells, Cultured; D002738:Chloroquine / Q000494:pharmacology; D004260:DNA Repair; D005347:Fibroblasts / Q000648:ultrastructure*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000235:genetics* / Q000276:immunology / Q000473:pathology; D008214:Lymphocytes / Q000648:ultrastructure*; D011239:Prednisolone / Q000494:pharmacology; D012854:Sister Chromatid Exchange / Q000187:drug effects; D012867:Skin
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000974:Antibodies, Antinuclear; D002738:Chloroquine; D011239:Prednisolone